165 related articles for article (PubMed ID: 34901156)
1. Bioinformatic Analyses and Experimental Verification Reveal that High FSTL3 Expression Promotes EMT
Liu Y; Li J; Zeng S; Zhang Y; Zhang Y; Jin Z; Liu S; Zou X
Front Mol Biosci; 2021; 8():762924. PubMed ID: 34901156
[No Abstract] [Full Text] [Related]
2. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
3. The cytoplasmic expression of FSTL3 correlates with colorectal cancer progression, metastasis status and prognosis.
Li CH; Fang CY; Chan MH; Chen CL; Chang YC; Hsiao M
J Cell Mol Med; 2023 Mar; 27(5):672-686. PubMed ID: 36807490
[TBL] [Abstract][Full Text] [Related]
4.
Liu YJ; Li JP; Zhang Y; Nie MJ; Zhang YH; Liu SL; Zou X
Onco Targets Ther; 2021; 14():4099-4117. PubMed ID: 34262295
[TBL] [Abstract][Full Text] [Related]
5. Follistatin-Like 3 Enhances Invasion and Metastasis via β-Catenin-Mediated EMT and Aerobic Glycolysis in Colorectal Cancer.
Li Y; Tian M; Liu W; Wang D; Zhou Z; Pei Q; Huang Y; Tan F; Güngör C
Front Cell Dev Biol; 2021; 9():660159. PubMed ID: 34395416
[TBL] [Abstract][Full Text] [Related]
6. FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer.
Li H; Zheng N; Guo A; Tang W; Li M; Cao Y; Ma X; Cao H; Ma Y; Wang H; Zhao S
Cell Death Dis; 2024 Feb; 15(2):107. PubMed ID: 38302412
[TBL] [Abstract][Full Text] [Related]
7. Follistatin-like 3 suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose.
Wang X; Shi L; Han Z; Liu B
Int J Clin Exp Med; 2015; 8(9):15214-21. PubMed ID: 26629006
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of follistatin-like 3 in human invasive breast cancer.
Couto HL; Buzelin MA; Toppa NH; Bloise E; Wainstein AJ; Reis FM
Oncotarget; 2017 Jun; 8(26):42189-42197. PubMed ID: 28178680
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of FSTL3, ADAM12, and FAT4 in Patients of Colon Cancer: Clinicopathologic Study.
Ibrahim HM; Abdelrahman AE; Elwan A; Bakry A; Fahmy MM; Abdelhamid MI; Abdelwanis AH; Fouad EM
Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):673-681. PubMed ID: 37751246
[TBL] [Abstract][Full Text] [Related]
10. HBXIP: a potential prognosis biomarker of colorectal cancer which promotes invasion and migration via epithelial-mesenchymal transition.
Wang X; Feng Q; Yu H; Zhou X; Shan C; Zhang Q; Liu S
Life Sci; 2020 Mar; 245():117354. PubMed ID: 31987874
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of NREP Promotes Migration and Invasion in Gastric Cancer Through Facilitating Epithelial-Mesenchymal Transition.
Liu YJ; Zeng SH; Hu YD; Zhang YH; Li JP
Front Cell Dev Biol; 2021; 9():746194. PubMed ID: 34746143
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
[TBL] [Abstract][Full Text] [Related]
14. High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma.
Hou Y; Wang W; Zeng Z; Gan W; Lv S; Li T; Yan Z; Zhang R; Yang M
Aging (Albany NY); 2020 Nov; 12(21):21992-22018. PubMed ID: 33177246
[TBL] [Abstract][Full Text] [Related]
15. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.
Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D
Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858
[TBL] [Abstract][Full Text] [Related]
16. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization.
Liang ZX; Liu HS; Wang FW; Xiong L; Zhou C; Hu T; He XW; Wu XJ; Xie D; Wu XR; Lan P
Cell Death Dis; 2019 Nov; 10(11):829. PubMed ID: 31685807
[TBL] [Abstract][Full Text] [Related]
17. THBS1 facilitates colorectal liver metastasis through enhancing epithelial-mesenchymal transition.
Liu X; Xu D; Liu Z; Li Y; Zhang C; Gong Y; Jiang Y; Xing B
Clin Transl Oncol; 2020 Oct; 22(10):1730-1740. PubMed ID: 32052380
[TBL] [Abstract][Full Text] [Related]
18. The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Sun J; Ding C; Yang Z; Liu T; Zhang X; Zhao C; Wang J
J Transl Med; 2016 Feb; 14():42. PubMed ID: 26856330
[TBL] [Abstract][Full Text] [Related]
19. FLNA promotes chemoresistance of colorectal cancer through inducing epithelial-mesenchymal transition and smad2 signaling pathway.
Cheng M; Jiang Y; Yang H; Zhao D; Li L; Liu X
Am J Cancer Res; 2020; 10(2):403-423. PubMed ID: 32195017
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
[Next] [New Search]
